We terminate commissioned coverage on Etteplan. Note that estimates and information have not been up...
In this episode, we are joined by Jessica Martinsson, COO of Sprint Bioscience, alongside European p...
Ferronordic has today sold its Russian business for SEK 1.
Divests its Russian operations, gains SEK 75 per share We had no value on Russia for '23e and beyon...
Redeye will cease its coverage of Orexo, effective 21st December 2022.
Redeye strengthens its positive view on Transtema following the acquisitions of UBConnect.
Acquires Borö Pannan for SEK 110m (+30m earn-outs) Performs directed share issue of SEK 250m at SEK ...
Redeye comments on the outcome of Wylds networks warrants of series TO2.
Redeye updates its view on M.O.B.A. Network following its Q3 2022 report.
Redeye comments on the outcome of Alzecures oversubscribed rights issue and reiterate our base case ...
Sleep Cycle’s share has traded above the cash offer of SEK42.
Samtliga patienter till den pågående fas 2b-studien har rekryterats.
Redeye comments on Smart Wires additional preferred equity raise of USD5m and its full-year order bo...
Redeye comments on Artificial Solutions’ rights issue and updated terms with its debt provider.
Offentliggör utfall av nyemissionen OptiCept har offentliggjort utfallet av nyemissionen som meddela...
Divests Russian business, SEK 75 cash effect per share Ferronordic announced today that it divests i...
Redeye states that Norse Impact has received funding from Symetricus, a major European vape products...
Den virtuella satellitsnätsoperatören Wyld lanserad sin satellit-IoT-nätverkstjänst den 8 december o...
Ensurge Micropower has received its first production order, which is for 150,000 units of its rechar...
ChargePanel AB (publ) meddelade den 21 december att bolaget har ingått ett samarbete med P-Air AB (”...
